Skip to main content
. Author manuscript; available in PMC: 2022 Oct 1.
Published in final edited form as: J Pediatr. 2021 Jun 4;237:197–205.e4. doi: 10.1016/j.jpeds.2021.05.059

Table 7:

Test Characteristics for ultrasound findings to predict neurodevelopmental outcome. Test negative group consists of infants with neither IVH nor WMD. Test positive group consists of infants with ultrasound abnormality listed in the left-most column.

Prediction of neurological disorder
Sensitivity Specificity +LR −LR
Isolated IVH 21 (14, 29) 85 (82, 87) 1.4 (0.9, 2.0) 0.93 (0.85, 1.03)
Isolated WMD 16 (10, 24) 98 (96, 99) 8.2 (4.0, 16.7) 0.85 (0.8, 0.9)
IVH + WMD 27 (20, 36) 95 (93, 97) 6.0 (3.8, 9.6) 0.8 (0.7, 0.9)
Prediction of cognitive impairment
Sensitivity Specificity +LR −LR
Isolated IVH 20 (14, 27) 85 (82, 87) 1.3 (0.9, 1.8) 0.95 (0.87, 1.03)
Isolated WMD 10 (6, 16) 97 (95, 98) 3.3 (1.6, 6.5) 0.9 (0.88, 0.98)
IVH + WMD 21 (15, 29) 95 (93, 97) 4.2 (2.6, 6.6) 0.8 (0.76, 0.90)

Abbreviations: IVH- intraventricular hemorrhage; LR- likelihood ratio; WMD- white matter damage defined as cerebral echolucency or late moderate-to-severe ventriculomegaly

Neurological disorder refers to presence of cerebral palsy, autism spectrum disorder, and/or epilepsy